Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer?
Publication
, Journal Article
Kamal, A; Maguire, JM; Currow, DC; Abernethy, AP
January 1, 2012
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Kamal, A., Maguire, J. M., Currow, D. C., & Abernethy, A. P. (2012). Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer?, 59–64. https://doi.org/10.1016/B978-1-4377-3796-7.00012-4
Kamal, A., J. M. Maguire, D. C. Currow, and A. P. Abernethy. “Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer?,” January 1, 2012, 59–64. https://doi.org/10.1016/B978-1-4377-3796-7.00012-4.
Kamal A, Maguire JM, Currow DC, Abernethy AP. Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer? 2012 Jan 1;59–64.
Kamal, A., et al. Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer? Jan. 2012, pp. 59–64. Scopus, doi:10.1016/B978-1-4377-3796-7.00012-4.
Kamal A, Maguire JM, Currow DC, Abernethy AP. Should Bisphosphonates Be Used Routinely to Manage Pain and Skeletal Complications in Cancer? 2012 Jan 1;59–64.